Cargando…
Does the Time of Drug Administration Alter the Metabolic Risk of Aripiprazole?
Antipsychotic drugs cause metabolic abnormalities through a mechanism that involves antagonism of D(2) dopamine receptors (D(2)R). Under healthy conditions, insulin release follows a circadian rhythm and is low at night, and in pancreatic beta-cells, D(2)Rs negatively regulate insulin release. Since...
Autores principales: | Chipchura, Danielle A., Freyberg, Zachary, Edwards, Corey, Leckband, Susan G., McCarthy, Michael J. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6193090/ https://www.ncbi.nlm.nih.gov/pubmed/30364286 http://dx.doi.org/10.3389/fpsyt.2018.00494 |
Ejemplares similares
-
Dopamine D(2) receptors and the circadian clock reciprocally mediate antipsychotic drug-induced metabolic disturbances
por: Freyberg, Zachary, et al.
Publicado: (2017) -
Editorial: Neuroinflammation, metabolism, and psychiatric disorders
por: Freyberg, Zachary, et al.
Publicado: (2022) -
Does DRD2 Taq1A Mediate Aripiprazole-Induced Gambling Disorder? A Pharmacogenetic Hypothesis
por: Miuli, Andrea, et al.
Publicado: (2020) -
The Treatment of Adult Bipolar Disorder with Aripiprazole: A Systematic Review
por: Muneer, Ather
Publicado: (2016) -
Aripiprazole Long-Acting Injection During First Episode Schizophrenia—An Exploratory Analysis
por: Giordano, Gloria, et al.
Publicado: (2020)